AIRLINK 75.14 Increased By ▲ 1.44 (1.95%)
BOP 4.89 Decreased By ▼ -0.01 (-0.2%)
CNERGY 4.42 Decreased By ▼ -0.10 (-2.21%)
DFML 43.05 Decreased By ▼ -1.83 (-4.08%)
DGKC 84.08 Decreased By ▼ -1.42 (-1.66%)
FCCL 21.26 Decreased By ▼ -0.14 (-0.65%)
FFBL 32.22 Decreased By ▼ -0.29 (-0.89%)
FFL 9.44 Decreased By ▼ -0.15 (-1.56%)
GGL 10.07 Decreased By ▼ -0.20 (-1.95%)
HASCOL 6.99 Decreased By ▼ -0.14 (-1.96%)
HBL 114.00 Decreased By ▼ -0.70 (-0.61%)
HUBC 139.15 Increased By ▲ 0.05 (0.04%)
HUMNL 12.03 Decreased By ▼ -0.39 (-3.14%)
KEL 4.92 Decreased By ▼ -0.11 (-2.19%)
KOSM 4.38 Decreased By ▼ -0.07 (-1.57%)
MLCF 37.15 Decreased By ▼ -0.45 (-1.2%)
OGDC 133.95 Decreased By ▼ -2.85 (-2.08%)
PAEL 25.06 Decreased By ▼ -0.33 (-1.3%)
PIBTL 6.58 Decreased By ▼ -0.11 (-1.64%)
PPL 118.74 Decreased By ▼ -2.26 (-1.87%)
PRL 26.06 Decreased By ▼ -0.53 (-1.99%)
PTC 13.80 Decreased By ▼ -0.30 (-2.13%)
SEARL 56.80 Decreased By ▼ -0.50 (-0.87%)
SNGP 66.90 Decreased By ▼ -1.10 (-1.62%)
SSGC 10.31 Decreased By ▼ -0.11 (-1.06%)
TELE 8.28 Decreased By ▼ -0.17 (-2.01%)
TPLP 10.87 Decreased By ▼ -0.11 (-1%)
TRG 62.55 Decreased By ▼ -0.79 (-1.25%)
UNITY 27.15 Increased By ▲ 0.10 (0.37%)
WTL 1.35 Decreased By ▼ -0.03 (-2.17%)
BR100 7,890 Decreased By -50.2 (-0.63%)
BR30 25,320 Decreased By -327.4 (-1.28%)
KSE100 75,205 Decreased By -312.9 (-0.41%)
KSE30 24,145 Decreased By -133.1 (-0.55%)

Gilead Sciences, is a research-based biopharmaceutical company, has announced the recipients of its 2019 Gilead Asia Pacific Rainbow Grant programme, a regional grant initiative that supports community-led programmes for people living with HIV in the Asia Pacific region.

"This was the first time non-governmental or advocacy organizations in Pakistan were invited to submit their applications for funding. Of the 15 submissions received from Pakistan, Naz Male Health Alliance (NAZ), s a non-governmental technical support agency in Pakistan, is one of the three recipients selected to receive the grant," said a Gilead Sciences' spokesperson here on Tuesday.

Through this year's programme, Gilead is awarding a total of US $1.4 million to close to 40 projects across Asia Pacific. Of this over US $80,000 has been distributed across the three Pakistani recipients.

NAZ has received the grant to further efforts in their project 'Naz initiative to combat PLHIV stigma and discrimination'. It intends to alleviate the social stigma and to diversify the workplace through more inclusive HR policies for PLHIV. NAZ will develop a docu-drama and a supporting social media campaign. They will engage with corporations and conduct training sessions with their HR departments to sensitize them towards PLHIV and help them develop inclusive HR policies. Finally, they will also focus on engaging with universities to conduct an awareness campaign around the stigma attached to PLHIV.

Commenting on the grant, Dr Qasim Iqbal, Executive Director of NAZ Pakistan said, "The stigma and discrimination faced by HIV positive persons in a country like Pakistan is real. As a gay man living with HIV, I strongly believe that we need to re-strategize the programming to combat HIV related stigma and discrimination because the programming and interventions implemented throughout the globe thus far have not worked.

"We are grateful to Gilead for providing us the resources that will help us make life less stressful for the MSM and TGs living with HIV in Pakistan. We are excited about the potential impact we believe this project will make. With the generous funds from Gilead, we have planned to target the general population, employers and the youth."

Started in 2018, the Gilead Asia Pacific Rainbow Grant programme directly supports HIV-related community-led projects.

The programme is part of Gilead's broader efforts to enhance public-private partnerships in the Asia Pacific region to address the challenges facing communities affected by HIV.

Copyright Business Recorder, 2019

Comments

Comments are closed.